Your browser doesn't support javascript.
loading
Assessment of SGLT2 inhibitors' safety and discontinuation causes in patients with advanced chronic kidney disease: insights from a real-world data analysis.
Perrin, Peggy; Muller, Clotilde; Dimitrov, Yves; Chantrel, Francois; Heitz, Marie; Woerly, Amandine; Bazin, Dorothée; Faller, Anne-Laure; Krummel, Thierry; Hannedouche, Thierry.
Afiliação
  • Perrin P; Department of Nephrology, Dialysis and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Muller C; INSERM UMS S1109, LabEx Transplantex, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg University Hospital, Strasbourg, France.
  • Dimitrov Y; Department of Nephrology Groupe Hospitalier Saint-Vincent, Clinique Ste-Anne, Service de Néphrologie, Strasbourg, France.
  • Chantrel F; Renal Research Division, AURAL Strasbourg, Strasbourg, France.
  • Heitz M; Renal Research Division, AURAL Strasbourg, Strasbourg, France.
  • Woerly A; Department of Nephrology, CH Haguenau, Haguenau, France.
  • Bazin D; Renal Research Division, AURAL Strasbourg, Strasbourg, France.
  • Faller AL; Department of Nephrology Groupe Hospitalier de la Région Mulhouse et Sud Alsace, Hôpital Emile Muller, Mulhouse, France.
  • Krummel T; Department of Nephrology, Colmar Hospital, Colmar, France.
  • Hannedouche T; Department of Nephrology, Dialysis and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Clin Kidney J ; 17(7): sfae169, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39056068

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Clin Kidney J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Clin Kidney J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França